Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (331-340 of 340) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 340 results.
Gastroenterology|February 6, 2024
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) StudyNicolette J Rodriguez, C Sloane Furniss, Matthew B Yurgelun, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 9, 2021
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE StudyC Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
JAMA|December 11, 2008
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Eric A Klein, Phyllis J Goodman, et al.
The Journal of Clinical Investigation|June 20, 2013
Whole exome sequencing of adenoid cystic carcinomaPhilip J Stephens, Helen R Davies, Yoshitsugu Mitani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forwardGary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Mayo Clinic Proceedings|July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsAyalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Pageof 34

Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Gastroenterology|February 6, 2024
A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) StudyNicolette J Rodriguez, C Sloane Furniss, Matthew B Yurgelun, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 9, 2021
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE StudyC Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
JAMA|December 11, 2008
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Eric A Klein, Phyllis J Goodman, et al.
The Journal of Clinical Investigation|June 20, 2013
Whole exome sequencing of adenoid cystic carcinomaPhilip J Stephens, Helen R Davies, Yoshitsugu Mitani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forwardGary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Cancer Cell|May 9, 2025
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interceptionBo Zhu, Pingjun Chen, Muhammad Aminu, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Mayo Clinic Proceedings|July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsAyalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Pageof 34